PreMD Inc. Stock

Stocks

PREMF

CA74047Y1051

Pharmaceuticals

OTC Markets Traded
Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for PreMD Inc. -.--% -

Valuation : PreMD Inc.

Market Cap 461K 397K 373K 341K 638K 43.51M 639K 4.41M 1.71M 22.32M 1.73M 1.69M 71.92M P/E 2006
-5.86x
P/E 2007 -5.08x
Enterprise Value 4.9M 4.21M 3.97M 3.62M 6.78M 462M 6.79M 46.86M 18.18M 237M 18.39M 17.99M 764M EV / Sales 2006
11,468,067x
EV / Sales 2007 399,046,792x
Free-Float
70.7%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 65 09/11/1992
Director TitleAgeSince
Director/Board Member 65 09/11/1992
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 38
-0.89%-1.09%+19.16%+67.77% 48.26B
-1.72%-1.15%+45.80%+117.34% 40.5B
-0.70%-2.70%-10.84%+11.79% 11.85B
-2.01%-5.96%+10.47%+76.64% 11.83B
+2.31%0.00%+26.67%+153.33% 9.36B
+0.08%-4.11%+24.83%+43.80% 7.5B
-1.67%-0.35%+41.04%-11.59% 7.37B
-0.89%-3.09%+18.78%+207.82% 7.28B
-0.16%-2.36%-46.14%+16.28% 5.19B
Average -0.56%-1.89%+14.42%+75.91% 14.91B
Weighted average by Cap. -0.95%-1.71%+22.87%+82.78%

Financials

2006 2007
Net sales 3.34 2.87 2.7 2.47 4.61 314.91 4.63 31.91 12.38 161.57 12.52 12.25 520.5 0.09 0.08 0.08 0.07 0.13 8.92 0.13 0.9 0.35 4.58 0.35 0.35 14.75
Net income -5.95M -5.12M -4.82M -4.4M -8.23M -562M -8.25M -56.91M -22.08M -288M -22.34M -21.85M -928M -6.32M -5.43M -5.11M -4.67M -8.74M -596M -8.76M -60.42M -23.45M -306M -23.72M -23.2M -986M
Net Debt 3.07M 2.65M 2.49M 2.27M 4.25M 290M 4.27M 29.41M 11.41M 149M 11.55M 11.29M 480M 4.44M 3.82M 3.59M 3.28M 6.14M 419M 6.16M 42.45M 16.47M 215M 16.66M 16.3M 692M
Logo PreMD Inc.
PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company’s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company’s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.
Employees
-
  1. Stock Market
  2. Stocks
  3. PREMF Stock